News | March 28, 2022
Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India
The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment
The first-of-its-kind unique centre will increase access to preventive & primary care
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Enables millions of Indians to monitor their vitals without the need of any additional device
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
Subscribe To Our Newsletter & Stay Updated
